Application of insulin-like growth factor 1 in the treatment of inner ear disorders
Sensorineural hearing loss is considered an intractable disease, given that hair and supporting cells of the postnatal mammalian cochlea are unable to regenerate. However, with progress in regenerative medicine in the 21st century, several innovative approaches for achieving regeneration of inner ea...
Saved in:
Main Authors: | Norio eYamamoto (Author), Takayuki eNakagawa (Author), Juichi eIto (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss
by: Takayuki eOkano
Published: (2014) -
Strategies for developing novel therapeutics for sensorineural hearing loss
by: Takayuki eNakagawa
Published: (2014) -
Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders
by: Megumi Kishimoto-Urata, et al.
Published: (2022) -
Drug selection for inner ear therapy
by: Alec N. Salt, et al.
Published: (2024) -
Analysis of Pharmacokinetics in the Cochlea of the Inner Ear
by: Seishiro Sawamura, et al.
Published: (2021)